Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The Current State of Vaccine Development for Ocular HSV-1 Infection.
Journal: Expert review of ophthalmology
Published: May 19, 2015
Caveolin-1 increases proinflammatory chemoattractants and blood-retinal barrier breakdown but decreases leukocyte recruitment in inflammation.
Journal: Investigative ophthalmology & visual science
Published: August 28, 2014
Boston type 1 keratoprosthesis for chemical and thermal injury.
Journal: Cornea
Published: July 24, 2014
Boston keratoprosthesis type 1 for herpes simplex and herpes zoster keratopathy.
Journal: Cornea
Published: June 17, 2014
Boston type 1 keratoprosthesis for failed keratoplasty.
Journal: International ophthalmology
Published: May 26, 2014
Spatial and temporal localization of caveolin-1 protein in the developing retina.
Journal: Advances in experimental medicine and biology
Published: March 26, 2014
Loss of caveolin-1 causes blood-retinal barrier breakdown, venous enlargement, and mural cell alteration.
Journal: The American journal of pathology
Published: June 03, 2013
HSV-1 targets lymphatic vessels in the eye and draining lymph node of mice leading to edema in the absence of a functional type I interferon response.
Journal: The American journal of pathology
Published: May 14, 2013
The "silent brain syndrome" creating a severe form of the "giant fornix syndrome".
Journal: Cornea
Published: February 24, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026